# Electroencephalographic Characteristics of Chronic Pain in Patients With Spinal Cord Injury

> **NCT06531837** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** Esketamine(Continuous infusion)
- **DRUG:** Remifentanil (Target-Controlled Infusion)
- **DRUG:** Flurbiprofen (Single intravenous injection)
- **DEVICE:** Spinal Cord Stimulation
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06531837
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-25
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-02-28
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06531837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06531837, "Electroencephalographic Characteristics of Chronic Pain in Patients With Spinal Cord Injury". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06531837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*